These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10850423

  • 1. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
    Boley SE, Anderson EE, French JE, Donehower LA, Walker DB, Recio L.
    Cancer Res; 2000 Jun 01; 60(11):2831-5. PubMed ID: 10850423
    [Abstract] [Full Text] [Related]

  • 2. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D, Matsuki J, Saitou Y, Kosugi SI, Shinbo T, Gejyo F, Niwa O, Kominami R.
    Mol Carcinog; 1999 Nov 01; 26(3):157-62. PubMed ID: 10559790
    [Abstract] [Full Text] [Related]

  • 3. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
    Kakinuma S, Nishimura M, Kubo A, Nagai JY, Amasaki Y, Majima HJ, Sado T, Shimada Y.
    Mutat Res; 2005 May 02; 572(1-2):132-41. PubMed ID: 15790496
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ.
    Cancer Res; 2004 Aug 01; 64(15):5140-7. PubMed ID: 15289317
    [Abstract] [Full Text] [Related]

  • 5. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
    Tanaka K, Watanabe K, Mori M, Kamisaku H, Tsuji H, Hirabayashi Y, Inoue T, Yoshida K, Aizawa S.
    Int J Radiat Biol; 2002 Mar 01; 78(3):165-72. PubMed ID: 11869471
    [Abstract] [Full Text] [Related]

  • 6. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
    Hulla JE, French JE, Dunnick JK.
    Carcinogenesis; 2001 Jan 01; 22(1):89-98. PubMed ID: 11159746
    [Abstract] [Full Text] [Related]

  • 7. Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16.
    Matsumoto Y, Kosugi S, Shinbo T, Chou D, Ohashi M, Wakabayashi Y, Sakai K, Okumoto M, Mori N, Aizawa S, Niwa O, Kominami R.
    Oncogene; 1998 May 28; 16(21):2747-54. PubMed ID: 9652741
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
    Reese JS, Allay E, Gerson SL.
    Oncogene; 2001 Aug 30; 20(38):5258-63. PubMed ID: 11536039
    [Abstract] [Full Text] [Related]

  • 9. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein.
    Hulla JE, French JE, Dunnick JK.
    Toxicol Sci; 2001 Apr 30; 60(2):264-70. PubMed ID: 11248138
    [Abstract] [Full Text] [Related]

  • 10. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas.
    Shimada Y, Nishimura M, Kakinuma S, Okumoto M, Shiroishi T, Clifton KH, Wakana S.
    Radiat Res; 2000 Sep 30; 154(3):293-300. PubMed ID: 10956435
    [Abstract] [Full Text] [Related]

  • 11. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW, Blyth K, Cameron ER, Neil JC.
    J Virol; 2001 Oct 30; 75(20):9790-8. PubMed ID: 11559812
    [Abstract] [Full Text] [Related]

  • 12. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
    Shinbo T, Matsuki A, Matsumoto Y, Kosugi S, Takahashi Y, Niwa O, Kominami R.
    Oncogene; 1999 Jul 15; 18(28):4131-6. PubMed ID: 10435594
    [Abstract] [Full Text] [Related]

  • 13. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang SM, Eklund LK, Cochran C, Rao GN, Wiseman RW, Söderkvist P.
    Cancer Res; 1996 Jul 15; 56(14):3338-43. PubMed ID: 8764131
    [Abstract] [Full Text] [Related]

  • 14. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
    Buettner VL, Hill KA, Nishino H, Schaid DJ, Frisk CS, Sommer SS.
    Oncogene; 1996 Dec 05; 13(11):2407-13. PubMed ID: 8957082
    [Abstract] [Full Text] [Related]

  • 15. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas.
    Santos J, Pérez de Castro I, Herranz M, Pellicer A, Fernández-Piqueras J.
    Oncogene; 1996 Feb 01; 12(3):669-76. PubMed ID: 8637724
    [Abstract] [Full Text] [Related]

  • 16. Distinct structural abnormalities of chromosomes 11 and 12 associated with loss of heterozygosity in X-ray-induced mouse thymic lymphomas.
    Yoshida MA, Nakata A, Akiyama M, Kakinuma S, Sado T, Nishimura M, Shimada Y.
    Cancer Genet Cytogenet; 2007 Nov 01; 179(1):1-10. PubMed ID: 17981208
    [Abstract] [Full Text] [Related]

  • 17. Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene.
    Albertini RJ, Judice SA, Recio L, Walker VE.
    Chem Biol Interact; 2010 Mar 19; 184(1-2):77-85. PubMed ID: 20035728
    [Abstract] [Full Text] [Related]

  • 18. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H, Ishii-Ohba H, Katsube T, Ukai H, Aizawa S, Doi M, Hioki K, Ogiu T.
    Cancer Res; 2004 Dec 15; 64(24):8882-90. PubMed ID: 15604248
    [Abstract] [Full Text] [Related]

  • 19. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
    Nacht M, Jacks T.
    Cell Growth Differ; 1998 Feb 15; 9(2):131-8. PubMed ID: 9486849
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    French JE, Lacks GD, Trempus C, Dunnick JK, Foley J, Mahler J, Tice RR, Tennant RW.
    Carcinogenesis; 2001 Jan 15; 22(1):99-106. PubMed ID: 11159747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.